MedTrace Logo

Different Volumes of Durolane in Knee OA

NCT01265459 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-09-22

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the safety and efficacy profiles of new single-injection volumes of Durolane in patients with knee OA.

Conditions

Interventions

DEVICE

Durolane 3 ml, Durolane 4,5 ml, Durolane 6 ml

Durolane is an intraarticular hyaluronic acid preparation

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Per-Erik Melberg, MD · Kristinelundskliniken, Kristinelundsgatan 13, 411 37 Göteborg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-09-30
Completion
2011-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01265459 on ClinicalTrials.gov